Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
1.8%
1w
0.4%
1m
5.7%
3m
8.4%
6m
21.8%
1y
12.9%
5y
43.9%
10y
30.1%
all
19.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 184 1.8%
155
201
Company Overview

Sales
282 Cr
Growth: 13.1%
Profit after Tax
40.9 Cr
Growth: 5.5%
Small Cap
1,235 Cr
P/E: 30.3x
Industry P/E: 27.1x
Fundamentals

Sales (Cr) ₹ 282
Growth 13.1%
EBITDA 19.8%
P/S 4.4x
Dividend 1.2%
P/E 30.3x
Book Value ₹ 41
PEG Ratio 2.3x
ROE 15.9%
P/B 4.5x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (23)
Followers (1)